Navigation Links
Schering-Plough's Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
Date:3/12/2009

A Phase II Study Published in The Lancet of Fast-Tracked Antiplatelet Agent Showed No Increase in TIMI Major and Minor Bleeding and was Well Tolerated When Given With Standard Platelet Therapy

KENILWORTH, N.J., March 12 /PRNewswire-FirstCall/ -- Results of a Schering-Plough Corporation (NYSE: SGP) Phase II trial of SCH 530348, a novel oral thrombin receptor antagonist (TRA), were published today in The Lancet and demonstrated that the investigational antiplatelet compound met its primary endpoints of safety and tolerability. TRA showed no increase in major and minor Thrombolysis in Myocardial Infarction (TIMI)-scale bleeding when given with current standard antiplatelet therapy (aspirin and clopidogrel) for patients undergoing percutaneous coronary intervention (PCI), commonly known as balloon angioplasty with stenting.

"The results of this study are encouraging as they support the viability of TRA as a potential new antiplatelet therapy option," said Richard Becker, MD, director of the Duke Cardiovascular Thrombosis Center and lead author of the study. "TRA appears to work in a novel way that is complementary to current antiplatelet therapies," he further commented.

Another important result from the Thrombin Receptor Antagonist Percutaneous Coronary Intervention (TRA-PCI) trial was the rate of thrombin-receptor agonist peptide (TRAP)-induced platelet aggregation inhibition, a secondary endpoint. Thrombin is the most potent platelet activator, which leads to platelet aggregation and the development of blood clots. In the study, TRA showed a much higher TRAP-induced platelet aggregation inhibition compared to standard of care alone in both loading and maintenance doses.

"In this study, TRA, when given with aspirin and clopidogrel, was able to inhibit the aggregation of platelets even when
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
2. Daiichi Sankyo Initiates Phase III Trial of Its Investigational Factor Xa Inhibitor, DU-176b, in Patients With Atrial Fibrillation
3. Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial
4. Miami Jewish Home and Hospital, Berma Research Group and Segal Institute for Clinical Research Enrolling Local Patients in Study of Investigational Therapy to Treat Alzheimers Disease
5. Data From Investigational Use of PROCRIT(R) (Epoetin alfa) Presented at American Society of Nephrology Annual Meeting
6. Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
7. Tibotec Presents Interim Findings for TMC435, an Investigational Genotype 1 Hepatitis C Treatment, at the AASLD Liver Meeting 2008
8. Sequella Presents Data on Synergy Between Investigational New TB Drugs SQ109 and TMC207
9. Sequoia Pharmaceuticals Presents In Vitro and First-in-Human Data Supporting Further Development of SPI-256, a Novel Investigational Protease Inhibitor
10. Millennium Presents New Data on Investigational Drugs for Novel Cancer Targets at EORTC-NCI-AACR Symposium
11. Berlin Hearts EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , Jan. 15, 2014  Novation, the leading health ... several new IT value-added reseller (VAR) national contracts that ... goods and services at lower costs. These include manufacturer ... such as initiative assistance and ongoing IT consulting support. ...
(Date:1/15/2014)... plc (LSE: SHP, NASDAQ: SHPG ) announces that it ... the announced tender offer for all of the outstanding shares of ... the waiver, the transaction is no longer conditional on OFT approval, ... 2014 following the currently scheduled expiration time, subject to the satisfaction ...
(Date:1/15/2014)... , Jan. 15, 2014  Manufacturers, suppliers and ... be able to protect their most important business ... http://photos.prnewswire.com/prnh/20130716/CL46586LOGO ) Because of the ... steadfastly remains one of the most litigious industry ...
Breaking Medicine Technology:New Novation Information Technology VAR Contracts Offer Significant Savings to Hospitals 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Intellectual Property Insurance for Medical-related Products and Services 2
... SPRING HARBOR, N.Y., Sept. 1 The ASCO ... Advisory Committee (ODAC) recommendation that the breast cancer indication ... voting members, breast cancer specialists, oncologists in private practice, ... available online now at ASCOPost.com and appear in the ...
... According to Millennium Research Group (MRG), the global authority on ... continue to be used in a narrow set of indications ... grow at a much lower rate than previously expected.  With ... compared to the nonfusion market as a whole which is ...
Cached Medicine Technology:The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer 2The ASCO Post Publishes Multiple Perspectives on Outcome of ODAC Meeting Regarding Bevacizumab in Advanced Breast Cancer 3European Interspinous Process Decompression Device Market Will Grow Nominally at 1.2% over the Next Five Years 2European Interspinous Process Decompression Device Market Will Grow Nominally at 1.2% over the Next Five Years 3
(Date:4/24/2014)... April 24, 2014 Scientific research at UT ... heart can heal itself completely, whereas the adult heart ... today has revealed why the heart loses its incredible ... simple oxygen. , Yes, oxygen. It is ... to circulate oxygen-rich blood throughout the body. But at ...
(Date:4/24/2014)... patients before, during and after colorectal surgery cut hospital ... to researchers who led a study of the approach ... recovery, is easier on patients before surgery, doing away ... typically prescribed. After surgery, patients are encouraged to eat ... faster recoveries. , Among findings published in the May ...
(Date:4/24/2014)... terminology, and the relevance of palliation in advanced ... randomized controlled trials (RCTs). This is the result ... Quality and Efficiency in Health Care (IQWiG), which ... Together with external experts, IQWiG analysed studies on ... malignant melanoma, and pancreatic cancer. For this purpose, ...
(Date:4/24/2014)... team of researchers was the first in the world ... a tumour of the jaw. , Ameloblastoma is an ... treatment. Ameloblastoma is most often found in the posterior ... often resulting in tissue deficiencies in the jaws as ... therapy could reduce the need for surgery and the ...
(Date:4/24/2014)... the first flu pandemic in the 21st century. The ... than 50 people in the country. Since 2011 the ... seasons). , Infections with influenza pH1N1 virus vary ... has recommended Tamiflu for treatment of patients with severe ... that it targets viral proteins which mutate quickly and ...
Breaking Medicine News(10 mins):Health News:Oxygen diminishes the heart's ability to regenerate, researchers discover 2Health News:New approach for surgery patients cuts hospital stays and costs 2Health News:New approach for surgery patients cuts hospital stays and costs 3Health News:Palliation is rarely a topic in studies on advanced cancer 2Health News:Palliation is rarely a topic in studies on advanced cancer 3
... little difference in chemotherapy treatment; some critics say that,s ... -- A 2003 overhaul of Medicare that changed the ... alter cancer patients, perceptions of their quality of care, ... that cancer patients are waiting the same amount of ...
... Va., Oct. 8 A good night,s sleep,is ... an estimated 70,million Americans complain of sleeplessness. This ... (ACA) is offering,advice to help consumers select comfortable ... and neck pain., "Americans spend one-third of ...
... Ohio to make quality and safety list, AKRON, Ohio, ... named a "Leapfrog Top Hospital" for 2007. The only,facility in ... the nation,to make the list, Summa received this designation based ... a rating system that,assesses hospital quality and safety. According ...
... Oct. 8 Beginning in October, Concentra,("Concentra" or the ... For What Ails,You. This new theme is at the ... centers to various communities in the coming,year, beginning with ... area. The For What Ails You campaign is ...
... Oct. 8, 2007 /PRNewswire-FirstCall/,-- Although rising health ... America,s,local governments, most jurisdictions do not offer ... top health issues, according to,a survey of ... premier local,government leadership and management organization, and ...
... to Hear ... from Top Experts, SAN JOSE, Calif., ... Idiopathic Pulmonary Fibrosis (IPF),is the limitation the disease places on their ability ... that,obstacle for these patients by allowing them to "attend" a seminar,virtually and ...
Cached Medicine News:Health News:Medicare Changes Didn't Alter Cancer Care 2Health News:Medicare Changes Didn't Alter Cancer Care 3Health News:Medicare Changes Didn't Alter Cancer Care 4Health News:Proper Mattress Can Improve Sleep Comfort, Reduce Pain, Says American Chiropractic Association 2Health News:Proper Mattress Can Improve Sleep Comfort, Reduce Pain, Says American Chiropractic Association 3Health News:Summa Health System's Akron City Hospital Named 'Leapfrog Top Hospital' for 2007 2Health News:Concentra Offers a Cure 'For What Ails You' 2Health News:ICMA/CIGNA Survey: U.S. Cities and Counties Begin to Focus on Health Risks and Costs 2Health News:ICMA/CIGNA Survey: U.S. Cities and Counties Begin to Focus on Health Risks and Costs 3Health News:ICMA/CIGNA Survey: U.S. Cities and Counties Begin to Focus on Health Risks and Costs 4Health News:CPF 'Living with IPF' Patient Seminar to be Webcast Live October 13, 2007 2Health News:CPF 'Living with IPF' Patient Seminar to be Webcast Live October 13, 2007 3
... the storage of blood plasma in full ... attention to operating temperatures and performance means ... Standard freezer you will minimise bag cracking ... temperature an additional benefit is reduced thawing ...
Helmer offers Plasma Storage Freezer lines, the i.Series ipf 125-8. It is Designed to complement Blood Bank Refrigerators, it freezers offer outstanding features, including programmable defrost tim...
... PillCam SB Capsule Endoscope is a ... the gastrointestinal tract. Natural peristalsis moves ... painlessly throughout the gastrointestinal tract, transmitting ... The procedure is ambulatory, allowing patients ...
... 1400 Series Biosafety Cabinets ... revolutionize working in a ... most comfortable, quiet, and ... cabinet on the market, ...
Medicine Products: